Becton, Dickinson And Company last reported quarterly results on Nov 5, 2026, for Q4 FY2026 (the quarter ended Sep 30, 2026): diluted EPS of $2.54. It usually reports 2–40 days after a quarter ends. Based on that pattern, the next release is estimated for around Feb 8, 2027.
Results for Q1 FY2027, the quarter ending around Dec 31, 2026. Expected on a Monday. Based on last year's release for the same quarter on Feb 9, 2026. This is an estimate, not a date the company has announced.
Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 2–40 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.
| Released | Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|---|
|
Nov 5, 2026
36 days after quarter end
From press release
|
Q4 FY2026
ended Sep 30, 2026
|
—
|
696
+41.2%
|
2.54
+48.4%
|
|
Aug 6, 2026
37 days after quarter end
|
Q3 FY2026
ended Jun 30, 2026
|
4,983
+5.4%
|
377
-34.3%
|
1.37
-31.5%
|
|
Apr 2, 2026
2 days after quarter end
|
Q2 FY2026
ended Mar 31, 2026
|
4,714
+5.2%
|
-311
-201.0%
|
-1.11
-203.7%
|
|
Feb 9, 2026
40 days after quarter end
|
Q1 FY2026
ended Dec 31, 2025
|
5,252
+1.6%
|
382
+26.1%
|
1.34
+28.8%
|
|
Oct 15, 2025
15 days after quarter end
|
Q4 FY2025
ended Sep 30, 2025
|
8,301
+52.7%
|
493
+23.2%
|
1.71
+24.7%
|
|
Aug 7, 2025
38 days after quarter end
|
Q3 FY2025
ended Jun 30, 2025
|
4,726
-5.3%
|
574
+17.9%
|
2.00
+19.0%
|
|
May 1, 2025
31 days after quarter end
|
Q2 FY2025
ended Mar 31, 2025
|
4,480
-11.2%
|
308
-42.6%
|
1.07
-42.2%
|
|
Feb 5, 2025
36 days after quarter end
|
Q1 FY2025
ended Dec 31, 2024
|
5,168
+9.8%
|
303
+7.8%
|
1.04
+8.3%
|
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- BDX (NYSE)
- Fiscal year ends
- September 30
- Incorporated in
- NJ
- Headquarters
- Franklin Lakes, NJ
- SEC filer status
- Large accelerated filer
- SEC CIK
- 10795
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
- West Pharmaceutical Services Inc WST
All 151 Surgical & Medical Instruments & Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.